Bridging the Gap: Index Volume [International Conference on AIDS (12th: 1998: Geneva, Switzerland)]

46 data * decisions

12th World AIDS Conference

SKeyword Abstract
erns of use and efficacy in the French compassionate use pro 42303
V-antibody surveillance true?/Are Russian HIV-antibody surv 43126
paign based on survey on men in relationships with men in N 43282
nd STD clinic: Baseline /A randomised controlled trial of a sm 43311
Ilance using HIV testing /Towards real-time HIV surveillance u 43437
or HIV infection using from a rural Ugandan cohort/Evaluati 43446
V/AIDS and analysis of /Reporting system, surveillance of HI 43461
on constantly submitted /Lessons learned on trends in HIV/AI 43462
counselling and testing to estimate time trends in HIV inciden 43482
morbidity and mortality to monitor the impact of the epidemic/ 43494
e use of epidemiologic in HIV prevention community plannin 43501
Philippines: Analysis of from the National HIV Sentinel Surveil 521*/43508
IV/AIDS surveillance in the United States/Protection of HIV 44185
mplished using existing sources/Evaluating the economic co 44314
tion of an instrument to collection/Nurse assessment in an Al 60183
nd 1992/Using registry to estimate trends in survival after AID 60253
tment and quality of life for decision making in antiretroviral th 60435
d patients/Preliminary of a pilot study comparing two proteas 60791
A) study and enrollment /Issues of Italian Cohort Naive Antiretr 60929
a linked administrative database /Measuring the net hospital cost 24121
IV using an observation /Costing HIV using an observati 477*/24127
and results/An internet of information on HIV/AIDS drug 42240
nt treatment information /The development of Canada's I 42295
e chorus observational /Patterns of protease inhibitor us 42310
led in an observational /Treating HIV/AIDS: Reported u 42390
HORUS observational /Viral detectability and CD4 level 42403
HIV intervention studies for providers and researchers/D 43242
A European behavioural /A European behavioural 43317
on/HIV, AIDS and STD in use for the Western Pacific re 43460
n HIV/AIDS confidential /Securing confidence in an HIV/ 44184
ors using observational databases /Two methods to identify potent 13360
o choose/Public health: A client's right to choose/Publi 43557
others and adolescent daughters /Setting the stage for a family in 235*/13404
g prostituted women in Davao City/The role of peer counselling on 24326
mission of HIV/AIDS in City/Capability building of male gay 33587
tertainment industry in City, Philippines: An assessment/H 34295
r a nursing group in the day-bed AIDS/HIV unit - Clinical Hospital, 42465
atient caregivers in a day-care unit in Brazil: A qualitative study/ 24310
rence to treatments in a day-nursery /Adherence to treatments in a 34325
ent in an AIDS hospital day-unit in Brazil: Evaluation of an instrum 60183
en living with HIV/AIDS/ Day care house for women living with HIV/ 24280
in Nigeria/World AIDS (WAD) celebration: An organ for colla 34169
nces of the World AIDS campaign in Santos, Brazil/Results a 43211
e correlates at an urban day treatment center/Quality of life correla 14350
occupational risk in the care unit in Brazil/Inhalatory pentamid 22474
he effectiveness of one- workshops for persons living with HIV/ 24351
s retinitis (CMV-R) in a care health center (DCHC)/Intravitreal 32244
and testing on a same- basis using rapid tests, Kampala, Uga 33236
omen in Zambia/Same HIV voluntary counselling and testing ( 33282
E worldwide world AIDS campaign educates 1,200,000 African 33362
ctive patients/Hospital/: An alternative for assistance of HIV re 42468
ting algorithm for same results at the AIDS Information Centre, 135*/43109
ents while giving same HIV test results/Challenges encounter 43115
eople attending a same testing clinic (SDTC) discuss their nee 43144
s of costs in Brazil/One clinic (ODC) service to AIDS patient: A 44255
ion for nurse's team on care unit in Brazil, through the problem 60182
socially disadvantaged men in Flanders, Belgium/Tailoring for 60826
ZDV 200 mg TID plus ddC 0.75 mg TID versus ZDV 100 mg TID 12240
quinavir-SGC, d4T and ) initiation in previously untreated patie 21123
enced patients (ZDV + /ddl) with a low baseline HIV-1 viral loa 22344
usly treated with ZDV + /Virologic efficacy of 3TC + d4T vs. 3T 22376
/AZT) and zalcitabine ( ) for HIV/AIDS patients in San Lazaro 22409
g from AZT/3TC or AZT/ to other double NRTI combinations/Vi 32281
mparing AZT/ddltoAZT/ in Thailand/An effectiveness trial com 131*/42244
T and either 3TC, ddl or using LiPA HIV-1 RT assay/Analysis 60854
f transmitted ZDV- and ddl-resistant HIV-1 variants and natural p 41210, AZT/DLV, DDI/AZT or DDI/AZT/DLV /Partial restoration of HIV sp 31108
nations of didanosine ( DDI ), zidovudine (ZDV) and nevirapine (N 12253
ydroxyurea once daily/ once daily vs twice daily alone and als 12352
ne (NVP) + didanosine ( ) + lamivudine (3TC) - First experience 32393
f antiretrovirals (AZT + ddl vs. AZT + 3TC + indinavir) on T-cell fun 12200
ZDV), and didanosine ( )/Relationship between delavirdine (DL 12206
parative study of d4T + + IDV versus ZDV + 3TC + IDV in treat 12225

dine (d4T), didanosine ( ), and nelfinavir combination therapy in 12226
ts enrolled in the alpha trial/Immunologic and virologic marker 12234
efficacy of didanosine ( ) ~ stavudine (d4T) in high/low dose co 12241
dine (d4T)-didanosine ( ) in healthy volunteers/Evaluation of po 12374
d patients (ZDV + ddC/ ) with a low baseline HIV-1 viral load (m 22344
ine (d4T), didanosine ( ) and nevirapine (NVP) as initial antiretr 22357
nce-dailv therapv (NVP/ /3TC) for the IVDU HIV-1 infected popul 22398

-Keyword

Abstract

dine (d4T), didanosine ( ) and ritonavir as a triple therapy in antir
m patients on long-term therapy/Emergence of drug-resistant
EG, CIV IL2 with AZT + /IL2 in HIV patients: A randomized trial
ess trial comparing AZT/ to AZT/ddC in Thailand/An effectivene
s (AZT + 3TC vs. AZT + ) on cytokine production and apoptosis i
m efficacy and safety of and 3TC both once daily plus indinavir
ng AZT and either 3TC, or ddC using LiPA HIV-1 RT assay/An
ublic policy/ Deadly public policy/
ss to health care for the deaf: A necessity and enrichment/An adap
ere, Paris/Study of the population using the testing site for HI
ne substances to drug dealers /The harm reduction program in th
ards for 14 professions dealing with HIV/AIDS/Educational qualit
tricken area/"Dear Mr. Death ": Community bereavement for multi
prison workers in Brazil/: A sensitization workshop for prison
ble for Vpr-induced cell death /Cell cycle G2 arrest by HIV-1 Vpr is

22401
41224
41229
131*/42244
60657
60678
60854
44233
32424
60677
33414
13583
24246
24253
11141

ogression to AIDS and: Evidence from the HIV-ltalian seroc 12108
Outcome and cause of in a cohort of HIV-1 infected adults in 12143
AIDS defining event or in patients receiving a protease inhib 12282
portunistic infections or after highly active antiretroviral treat 12331
he USA/Higher rates of with non-AIDS-defining cancers am 13235
ogression to AIDS and among HIV seroconverters from Ital 13332
anism of bystander cell of CD8 T cells induced by CD4 cross 274*/21159
inducer of CD4+ T cell in HIV-1-infected subjects: Inhibition 21160
activation-induced cell in primary acute infection/Expressio 21161
he load: Reports of the of AIDS activism have been greatly 24142
s of AIDS as a cause of in Catalonia (Spain): 1985-1995/C 24190
plans for children after among HIV positive women in Sao P 24217
e impact of HIV-related on women's mental health/"A grief o 24245
n AIDS-related assisted /The reasons for and timing of an Al 24250
es in AIDS care/Giving: Voices of Canadian nurses in AIDS 24252
n to cope with illness or in the family, by improving communi 24298
t associated with risk of /Levels of specific cytotoxic T-cell (C 31155
ogression to AIDS and in HIV infected patients/HIV-1 RNA, 32195
ning for children before with single mothers in the Slums of 48*/34187
linical progression and in a cohort of HIV-infected patients. 42188
Police concepts on risk, and HIV/AIDS in Colombia/Police c 43383
estigation of cases and s by AIDS from death certificates/Inv 43458
endence of predictors of in HIV-infected patients/Time-depe 43468
ed to programmed cell and accepted markers of disease pr 60393
e of families towards the of an AIDS patient/Attitude of famili 60566
ted with declining AIDS deaths in New York City (NYC)/Protease i 12280
Decline in AIDS-related at a university hospital in Rio de Ja 13176
ty analysis/Increase in due to causes unrelated to HIV infe 13196
n AIDS diagnoses and direct a shift to integrated HIV/AID 13219
ospital admissions and /The impact of highly active antiretr 22373
falling AIDS cases and in Scotland/Changing patterns in u 22394
AIDS in Malawi/Illness,,and social obligations: Peasant fo 24159
of multiple AIDS related on Perth's health care professional 24299
uction in the number of among patients of an AIDS referral 42319
estigation of cases and by AIDS from death certificates/Inv 43458
II prevent thousands of and AIDS diagnoses, and is afford 482*/44241
vercoming the unfruitful debates: Toward a comprehensive Christi 34202
CR) on plasma HIV RNA decay /Effect of processing delay, anticoa 42144
p (gam's): beginning its decentralization /Groups of mutual help ( 34304
oire/Minimizing cost of of care to AIDS/HIV patie 43519
DS: A multi-disciplinary, decentralized, collaborative project in Wa 24209
uterized, facility-based, reporting systems for monit 34323
antiretroviral treatment: Decision-making in general practice/Initi 60310
oes not affect sexual decision-making among the majority of m 23130
ceptive use and fertility among HIV-1 infected w 24197
ation dissemination and among HIV-positive per 42237
formation seeking and decision making behavior among HIV posi 12456
fluencing reproductive making in women with HIV infecti 14187
ARF)/Potential role for analysis in end-of-life decision m 22436
n skills in the treatment making process/Partners in care 33520
ation facilitates clinical making by integrating medication 42419
r violence and women's to have an HIV test/Partner viole 43110
nment/Inducing pivotal makers in effecting behaviour ch 43301
< 75/mm3: An updated analytic view/Disseminated Myc 43481
ion of a blood exclusion /Implicit valuation of a blood excl 484*/44244
unselling and testing: A analysis/Cost-effectiveness of p 44248
the religious tribal ARs maker on the gross root level/Pr 60005
ed women/Pregnancy making in a well-motivated cohor 60372
nd quality of life data for making in antiretroviral therapy/ 60435

rtner: Perception and decisions related to risk for HIV infection a
aviour and reproductive among HIV+ women in Sao Pau
egnancy intentions and of African-American women livi
ake effective treatment /HIV treatment compliance (adh
ople making treatment /It's not just about taking those p
nce to inform pragmatic in HIV prevention and to identify

23448
23480
24195
32363
42233
43524..__ - - I I \

I -. - / I - 1 1 ** - ",,,, - - - - F -